Medical Affairs Manager

Medical Affairs Managers occupy a specific and consequential position in pharmaceutical and biotech companies: they are the scientifically credentialed professionals responsible for communicating what a drug actually does, based on the totality of clinical evidence, rather than what marketing would like it to be seen as doing. That distinction defines the function and creates its value.

On any given week, a Medical Affairs Manager might review a new MSL territory call plan, prep an advisory board agenda for an upcoming congress, respond to a question from the commercial team about using off-label data in a formulary discussion, and brief a regional vice president on a competitor's Phase 3 readout that could affect market positioning. The work is genuinely cross-functional — these managers are in meetings with Regulatory, Commercial, Market Access, Clinical, and Legal, often on the same day.

The medical science liaison team, when one exists, is typically the largest operational responsibility. MSLs are field-based PhDs and PharmDs who meet with physicians and researchers to discuss clinical data. The manager sets the scientific strategy those conversations follow, trains the field team, and is accountable for whether the exchange program is compliant, scientifically sound, and strategically useful.

Publication planning is another significant workload item, especially around major data readouts. When a pivotal trial completes, the medical affairs team helps determine where and when data gets published, who the authors are, and how congress presentations are sequenced to maximize scientific credibility.

The job requires genuine scientific fluency — enough to evaluate clinical trial design, understand statistical endpoints, and identify where data limitations are material to how a drug is being communicated. It also requires the interpersonal skills to influence without authority across functions that often have conflicting priorities.

Degrees and credentials:

• MD, PharmD, or PhD in pharmacology, biochemistry, immunology, or a related biomedical field
• Master's degree candidates considered if MSL experience and track record are strong
• MBA or management training valued for roles with direct reports and budget accountability

Industry experience:

• 5–8 years in medical affairs, medical information, clinical development, or a related pharma/biotech function
• Prior experience as an MSL or medical science liaison is the most common pathway to management
• Background in academic medicine or clinical practice is valued for therapeutic area credibility

Technical knowledge:

• Clinical trial design: randomization, endpoints, statistical significance, non-inferiority
• FDA regulatory framework: 21 CFR Part 312, OPDP guidance on medical communications
• Publication planning: ICMJE authorship standards, congress abstract submission timelines, embargo policies
• Medical information systems: platforms like MIMS or Vault Vault MedComms
• KOL mapping and engagement tracking tools

Compliance literacy:

• PhRMA Code and OIG guidelines on industry-HCP interactions
• Sunshine Act and open payments documentation requirements
• Off-label communication rules and the boundaries of scientific exchange

Soft skills that separate candidates:

• Ability to translate complex clinical data into clear, defensible scientific narratives
• Comfort managing upward and influencing commercial stakeholders without losing scientific independence
• Precision in written materials — a single inaccurate claim in an approved document creates compliance exposure

Medical Affairs has been one of the faster-growing functions in the pharmaceutical industry over the past decade. Companies have expanded medical affairs headcount as the line between scientific communication and promotional activity has become more heavily scrutinized by FDA, and as payers have demanded increasingly rigorous evidence packages to justify formulary placement.

Therapeutic area concentration matters significantly to outlook. Oncology, rare disease, immunology, and neuroscience have the most active pipelines and the highest demand for medical affairs talent. Metabolic disease and cardiovascular are stable but less active in new asset development. Gene therapy and cell therapy represent an emerging frontier where medical affairs frameworks are still being built, and experienced managers who move into these areas early often end up shaping the function from the ground up.

The career ladder from Medical Affairs Manager typically runs toward Director of Medical Affairs, VP of Medical Affairs, and Chief Medical Officer for those on a senior leadership track. Some managers move laterally into medical strategy consulting, where the same skills command strong consulting fees on a project basis.

Headcount projections from industry analysts suggest continued growth at the manager level through the late 2020s, driven by pipeline expansion at large pharma and the continued maturation of biotech companies that hire medical affairs professionals for the first time when they reach late-stage development or launch stage. The function is recession-resistant in the sense that drug launches don't pause in downturns, though hiring can slow when a pipeline hit a difficult regulatory period.

Total compensation for experienced Medical Affairs Managers at top-tier pharma companies compares favorably to clinical medicine for physicians who prefer industry careers, and the lifestyle factors — predictable hours, no call schedule, no malpractice — are meaningful to many clinicians who make the transition.

Dear Hiring Manager,

I'm applying for the Medical Affairs Manager position at [Company]. I spent my first three years post-fellowship as an MSL in oncology at [Company], covering academic medical centers and community oncology practices in the Northeast. For the past two years I've been a senior MSL, taking on informal leadership of our regional team and mentoring two new liaisons through their first year of field work.

The transition from academic medicine to medical affairs was deliberate. I found that my most useful contributions in clinical practice were helping colleagues think through complex cases — synthesizing evidence, identifying where the data was and wasn't reliable, explaining mechanism. Medical affairs is that work at scale, and the opportunity to influence how an entire therapeutic community understands a drug's evidence base is genuinely motivating.

In my MSL role I've supported three advisory board meetings, contributed to a KOL engagement strategy for our upcoming label expansion, and worked with medical information to update four response letters following the publication of our Phase 3b data. I've also presented at two regional medical education programs and gotten comfortable facilitating scientific discussions that stay compliant without feeling artificially constrained.

I'm looking for a management role where I can build on that experience and take ownership of a field team and strategic program. [Company]'s pipeline in [therapeutic area] is a genuine scientific interest area for me — I've followed the mechanism since graduate school — and I'd welcome the opportunity to discuss the role.

[Your Name]